Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Free Cash Flow (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Free Cash Flow for 16 consecutive years, with $3025.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 99.84% to $3025.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Dec 2025, up 812.39% year-over-year, with the annual reading at $4.8 million for FY2025, 812.39% up from the prior year.
  • Free Cash Flow hit $3025.0 in Q4 2025 for Cumberland Pharmaceuticals, down from $163392.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $5.2 million in Q2 2023 to a low of -$2.2 million in Q1 2024.
  • Historically, Free Cash Flow has averaged $1.2 million across 5 years, with a median of $1.1 million in 2023.
  • Biggest five-year swings in Free Cash Flow: soared 1670.68% in 2022 and later tumbled 759.5% in 2023.
  • Year by year, Free Cash Flow stood at $2.0 million in 2021, then soared by 94.38% to $3.8 million in 2022, then tumbled by 73.85% to $991448.0 in 2023, then soared by 91.87% to $1.9 million in 2024, then crashed by 99.84% to $3025.0 in 2025.
  • Business Quant data shows Free Cash Flow for CPIX at $3025.0 in Q4 2025, $163392.0 in Q3 2025, and $817315.0 in Q2 2025.